Sat.May 11, 2024 - Fri.May 17, 2024

article thumbnail

The only tribal medical school in the U.S. graduates its first Native American doctors

STAT

There are so few Indigenous physicians in the United States — just 0.3% of doctors — that their numbers barely show up in charts and graphs depicting the diversity of the medical workforce. But as of Thursday, there will be at least nine more. Thursday is graduation day for the first class of the nation’s only tribally affiliated medical school, the Oklahoma State University College of Osteopathic Medicine at the Cherokee Nation.

article thumbnail

Big Pharma’s most improved drugs: a new generation of blockbusters

PharmaVoice

The old guard of pharma bestsellers is seeing more competition, but newer drugs demonstrating sales and revenue growth can build up the coffers in years to come.

222
222
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Investors put $400M into biotech licensing obesity drugs from China

BioPharma Dive

The biotech, tentatively named Hercules CM Newco, has rights to three incretin drugs discovered by Jiangsu Hengrui Pharmaceuticals, two of which are in clinical testing.

142
142
article thumbnail

Takeda wagers up to $2.2bn on AC Immune Alzheimer’s shot

pharmaphorum

Takeda has made a strong play for a stake in the Alzheimer’s disease market, paying $100 million upfront for an option on AC Immune’s amyloid-targeting immunotherapy. The option fee could be followed by another up to $2.1 billion in potential milestones if Takeda takes global rights to the programme, currently headed by ACI-24.060 which is in a phase 1b/2 trial with new data due in the next few weeks.

Immunity 132
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

In military medicine, study shows rank and race affect care

STAT

Higher ranking military officers receive more resources and better care than low ranking military officers, according to an analysis of 1.5 million military ER visits published Thursday in the journal Science. The study also showed that white physicians expended less effort on Black patients, even when rank was taken into account: Higher ranking Black officers received care from white physicians that was similar to that received by lower ranking white officers.

362
362
article thumbnail

5 trends impacting drug spend in the U.S.

PharmaVoice

Key factors changing how much Americans spend on prescriptions.

268
268

More Trending

article thumbnail

Prescription requests down by 16% due to ICB sustainability campaign

The Pharmacist

A local campaign to reduce prescriptions as part of a drive for sustainability has seen up to a 16% drop in requests for prescriptions. In February, Dorset integrated care board (ICB) launched the campaign to ‘only order what you need’ to address patients’ beliefs that they had to reorder all their medicines every time they got […] The post Prescription requests down by 16% due to ICB sustainability campaign appeared first on The Pharmacist.

124
124
article thumbnail

My rendezvous with the raw milk black market: quick, easy, and unchecked by the FDA

STAT

WASHINGTON — It’s Friday May 10, and I’m on my way to what feels like the world’s weirdest drug deal. I received a text the day before from a man named Karl. My order would be arriving from Maryland between 2 and 4 p.m. at the northwest D.C. drop site. It’ll be safely wrapped in ice packs, he assured me.

363
363
article thumbnail

GSK, UK govt put £130m into antimicrobial resistance fight

pharmaphorum

GSK has become the first founding partner of the new Fleming Initiative, which aims to tackle the rising threat of antimicrobial resistance (AMR) and is also backed by the UK government.

119
119
article thumbnail

Biogen, Ionis shelve ALS drug following study failure

BioPharma Dive

While results indicated the drug works as intended, it didn’t have enough of an effect on a protein that’s become integral to many ALS research programs.

124
124
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Ten pharmacies closing every week, NPA analysis suggests

The Pharmacist

The equivalent of 10 local pharmacies are closing their doors each week, according to analysis by the National Pharmacy Association (NPA). And the number of bricks and mortar pharmacies closing between January and April 2024 is nearly 50% higher than in the same period last year, the NPA said. The association’s analysis of NHS Business […] The post Ten pharmacies closing every week, NPA analysis suggests appeared first on The Pharmacist.

122
122
article thumbnail

USDA, FDA turf battles hamper responses to outbreaks like H5N1 bird flu

STAT

WASHINGTON — On a bright June day in 2018, one of the nation’s top regulators waved groceries in the air, quizzing the secretary of agriculture on which agency is charged with monitoring different types of food. Scott Gottlieb, the commissioner of the Food and Drug Administration at the time, grinned widely as he held liquid egg whites and a carton of eggs.

362
362
article thumbnail

ICER raps conduct of Lykos’ psychedelic trial for PTSD

pharmaphorum

The Institute for Clinical and Economic Review (ICER) typically focuses on the cost-effectiveness of new therapies, but in an unusual move has sharply criticised the design and conduct of clinical trials of Lykos Therapeutics psychedelic therapy for post-traumatic stress disorder (PTSD).

119
119
article thumbnail

Lilly’s once-weekly insulin matches daily shots in late-stage tests

BioPharma Dive

The results, which showed Lilly’s drug was as effective at controlling blood sugar as standard injections, come as Novo Nordisk seeks approval for a competing once-weekly insulin.

117
117
article thumbnail

BREAKING: Government publishes hub and spoke consultation response

The Pharmacist

Hub and spoke dispensing between pharmacies owned by different legal entities will be allowed from 1 January 2025, subject to parliamentary approval, the government has announced. In its consultation response published today, the government proposed introducing two models of hub and spoke dispensing across legal entities. In one model the hub would directly supply the […] The post BREAKING: Government publishes hub and spoke consultation response appeared first on The Pharmacist.

120
120
article thumbnail

CDC launching wastewater dashboard to track bird flu virus spread

STAT

Reluctance among dairy farmers to report H5N1 bird flu outbreaks within their herds or allow testing of their workers has made it difficult to keep up with the virus’s rapid spread , prompting federal public health officials to look to wastewater to help fill in the gaps. On Monday, the Centers for Disease Control and Prevention is expected to unveil a public dashboard tracking influenza A viruses in sewage that the agency has been collecting from 600 wastewater treatment sites around the

361
361
article thumbnail

FT US Pharma and Biotech Summit: Live coverage

pharmaphorum

Explore innovation, investment, and policies at the US Pharma and Biotech Summit 2024. Join industry leaders, regulators, and investors to discuss trends shaping healthcare.

119
119
article thumbnail

Eisai sets new revenue target for Alzheimer’s drug Leqembi

BioPharma Dive

The annual forecast, which comes as Eisai and Biogen have begun submitting a more convenient form of Leqembi for approval, looks “more realistic” than previous guidance, according to Jefferies analysts.

117
117
article thumbnail

Government plans to 'ensure accountability and patient safety' in hub and spoke

The Pharmacist

Mitigations and proposed legislative amendments will 'ensure patient safety, transparency and accountability’ in hub and spoke changes, the government has said in its consultation response. The planned changes will allow hubs to assemble medicines and then send them to back to the spoke for supply to the patient, or directly to the patient. This second […] The post Government plans to 'ensure accountability and patient safety' in hub and spoke appeared first on The Pharmacist.

118
118
article thumbnail

Opinion: As childhood asthma worsens, insurers restrict access to an essential medication

STAT

As pediatricians who take care of children in the inpatient, emergency, and primary care settings, we are alarmed by the recent trend of families having to go without basic medications to control their child’s asthma. At least seven children have died due to uncontrolled asthma this year in the Philadelphia region, a dramatic increase from prior years.

Inpatient 355
article thumbnail

Transforming clinical trials with open-source tech

pharmaphorum

Think open-source is just for software? Think again. Learn how clinical researchers are embracing open data and tools to overhaul the drug development process.

article thumbnail

PulmCrit: Why the new study associating piptazo with increased mortality is wrong

EMCrit Project

Piperacillin-tazobactam is an antibiotic that a lot of people love to hate. Combine this with the conservatism that often (rightfully) surrounds drug safety, and it creates a lot of volatility. Before going further, we should review some recent history regarding piptazo. In the early 2010's, a series of retrospective correlational studies found that patients treated […] EMCrit Project by Josh Farkas.

113
113
article thumbnail

NPA hands DHSC giant invoice for '£108m monthly shortfall'

The Pharmacist

National Pharmacy Association (NPA) leaders have delivered a giant invoice for the £108m they say is owed to the sector for dispensing at a loss over the last month. And pharmacy owners can generate their own individual invoice using a new tool launched by the NPA, which indicates the funding shortfall for each pharmacy based […] The post NPA hands DHSC giant invoice for '£108m monthly shortfall' appeared first on The Pharmacist.

115
115
article thumbnail

STAT+: CVS is willing to dump 10% of its Medicare Advantage members next year

STAT

CVS Health is preparing to make significant changes to its 2025 Medicare Advantage plans, which could potentially drive away 10% of its membership, the company’s chief financial officer said at an investment banking conference Tuesday. “The goal for next year is margin over membership,” CVS CFO Tom Cowhey said at the conference, hosted by Bank of America.

354
354
article thumbnail

Bayer cutbacks start to be felt with 1,500 jobs shed in Q1

pharmaphorum

Bayer's first-quarter results update shows its headcount has shrunk by around 1,500 since the start of the year, suggesting promised job cuts are starting to take hold

118
118
article thumbnail

FDA approves Amgen’s Imdelltra for extensive-stage small cell lung cancer

Pharmafile

Amgen has announced that the US Food and Drug Administration (FDA) has approved Imdelltra (tarlatamab-dlle) for the treatment of adult patients with extensive-stage small cell lung cancer (ES-SCLC) who have had disease progression on or after platinum-based chemotherapy. The post FDA approves Amgen’s Imdelltra for extensive-stage small cell lung cancer appeared first on Pharmafile.

article thumbnail

CPE 'already working with DHSC' on implications of hub and spoke changes

The Pharmacist

Community Pharmacy England (CPE) has already begun working with the Department of Health and Social Care (DHSC) on how hub and spoke arrangements will work for NHS services in England, it has told The Pharmacist. This comes as the government plans to allow models of hub and spoke dispensing across different legal entities that could supply […] The post CPE 'already working with DHSC' on implications of hub and spoke changes appeared first on The Pharmacist.

article thumbnail

STAT+: Data integrity watchdogs call for stronger safeguards in scientific journals

STAT

SAN FRANCISCO — According to Elisabeth Bik, a scientific watchdog who has discovered thousands of errors in scientific papers, the problem of fraud, errors, or data mishandling in the scientific literature seems to be getting worse. In the last couple of years, Bik’s been seeing an influx of AI-generated papers in the scientific record that are “nonsensical and clearly low quality.

349
349
article thumbnail

A greener catalysis: Talking sustainable, scalable chemistry with KCL

pharmaphorum

Explore sustainable catalysis and its potential to transform chemical reactions in drug discovery. Learn how green chemistry plays a pivotal role in shaping the future of catalysis.

115
115
article thumbnail

When Worlds Collide: The Theory of Real-World Evidence Meets Reality

FDA Law Blog: Biosimilars

By Jeffrey N. Gibbs & Ana Loloei & Véronique Li, Senior Medical Device Regulation Expert — FDA has long touted the use of real-world evidence ( RWE ). Extolling RWE, FDA has said “RWE can be leveraged to bring new products to market, evaluate the safety and effectiveness of existing products for new uses, and assess the continued performance and safety of products once on the market.

article thumbnail

GLP-1R agonists’ type 2 diabetes and obesity market to reach $125 billion in 7MM by 2033: GlobalData

Express Pharma

Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of incretin mimetic medicines for the treatment of type 2 diabetes and obesity. With the obesity and type 2 diabetes markets growing at unprecedented rates, the GLP-1 receptor agonists market is also growing. GLP-1 receptor agonist sales for the type 2 diabetes and obesity markets are forecast to reach over $125 billion in the seven major markets (7MM*) by 2033, according to GlobalData.

Diabetes 109
article thumbnail

Animal studies lend support to an innovative HIV vaccine strategy — but there’s still a long way to go

STAT

HIV has long stumped immunologists looking to develop an effective vaccine. All of the most promising approaches pioneered in the past three and a half decades have ultimately failed, and only a few months ago, the last trial expected to potentially deliver a vaccine within this decade was shut down. But HIV scientists are nothing if not resilient, and used to trying one new approach after another.

Vaccines 341
article thumbnail

Is digital therapeutics innovation enough for a sustainable future?

pharmaphorum

Digital therapeutics are transforming healthcare, but are they enough for a sustainable future? This post discusses whether innovation in digital therapeutics that empower patients is sufficient for long-term sustainability.

113
113
article thumbnail

Hub and spoke discussions in Scotland won’t start until funding agreed, says CPS

The Pharmacist

Community pharmacy negotiators in Scotland will not begin conversations about how new hub and spoke legislation will affect NHS dispensing until the sector has its funding in place for 2024/25, Community Pharmacy Scotland (CPS) has confirmed to The Pharmacist. Meanwhile, negotiators in Northern Ireland have expressed disappointment that the government has proceeded with the spoke-hub-patient […] The post Hub and spoke discussions in Scotland won’t start until funding agreed, says CPS appea

article thumbnail

Growth Guardian I Sanjaya Mariwala, Executive Chairman and Managing Director, OmniActive Health Technologies

Express Pharma

In this special edition of the Express Pharma-NutrifyToday Boardroom Series, we introduce you to Sanjaya Mariwala, Executive Chairman and Managing Director, OmniActive Health Technologies, one of the six Growth Guardians who will judge the merit of the contestants during the Nutrify C Suite Sumflex – Innovation Battlefield. As the Founder President of the Association of Herbal and Nutraceuticals Manufacturers of India (AHNMI), Mariwala has also gained quite a reputation as a mentor and angel inv

107
107